Currently predicting for Mon, 1 Apr 2024

Trading levels for GALT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.50 4.45 %
R2 2.45 2.53 %
R1 2.42 1.35 %
Current price: 2.39
Support S1 2.33 -2.48 %
S2 2.30 -3.66 %
S3 2.26 -5.57 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 2.44 2.09 %
R1 2.41 0.84 %
Current price 2.39
Support S1 2.06 -13.81%
S2 1.89 -20.92%
S3 1.86 -22.18%

GALT Predictions History

2 years ago
JS predicted that GALT for 2021-05-04 is going $3.71 (-7.71%)

2 years ago
Baltzera predicted that GALT for 2021-05-04 is going

2 years ago
JS predicted that GALT for 2021-04-21 is going $2.66 (-9.83%)

2 years ago
mgordon.mpc.233649 predicted that GALT for 2021-04-21 is going

Rank:

3 years ago
JS predicted that GALT for 2021-02-10 is going $2.44 (-5.06%)

3 years ago
Joel.Prudencio.1392 predicted that GALT for 2021-02-10 is going $2.48 (-3.50%)

Rank:

3 years ago
JS predicted that GALT for 2021-01-25 is going $2.17 (0.93%)

3 years ago
Baltzera predicted that GALT for 2021-01-25 is going

3 years ago
João Martins predicted that GALT for 2021-01-25 is going

Rank:

3 years ago
JS predicted that GALT for 2020-08-14 is going $2.82 (-8.14%)

Click to get the best stock tips daily for free!

About Galectin Therapeutics Inc.

Galectin Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT